Young Yiul Lee
Overview
Explore the profile of Young Yiul Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
359
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Yoon J, Kim J, Park H, Kim E, Ahn K, Yoon S, et al.
Int J Oncol
. 2008 Jan;
32(2):387-96.
PMID: 18202761
1alpha,25-dihydroxyvitamin D3 [1,25(OH)2D3] is capable of inhibiting the proliferation of acute myelogenous leukemia (AML). However, toxicity of hypercalcemia has limited the use of 1,25(OH)2D3 in clinical trials. We have evaluated...
22.
Kim B, Bae E, Kim Y, Ahn K, Park J, Rhee J, et al.
Anticancer Drugs
. 2007 Sep;
18(6):641-7.
PMID: 17762392
Although STI571 still plays a key role in the treatment of chronic myeloid leukemia, emergence of resistance to STI571 is a major obstacle to successful outcome. Therefore, new agents that...
23.
Kim J, Kim J, Kim B, Chung H, Lee Y, Park C, et al.
Exp Mol Med
. 2006 Jan;
37(6):601-7.
PMID: 16391521
Nanog, a homeodomain (HD) transcription factor, plays a critical role in the maintenance of embryonic stem (ES) cell self-renewal. Here, we report the identification of an alternatively-spliced variant of nanog....
24.
Kim J, Oh S, Park H, Yoon J, Kim E, Kim E, et al.
Oncol Rep
. 2005 May;
13(6):1177-83.
PMID: 15870940
The purpose of this study was to investigate the radioprotective effect of HGFs (GM-CSF, IL-3 and SCF) in irradiated human peripheral blood mononuclear cells (PBMCs) in vitro, and the survival...
25.
Cho H, Kim I, Park H, Ahn M, Lee Y, Park C
Korean J Intern Med
. 2004 Sep;
19(2):124-7.
PMID: 15366645
Chronic infection with Epstein-Barr virus (EBV) without previous immunodeficiency or immuno-suppressive therapy is relatively rare. Severe chronic active EBV (SCAEBV) infection was reported for the first time in 1984 as...
26.
Jung C, Kwon J, Seol J, Park W, Hyun J, Kim E, et al.
Am J Hematol
. 2004 Feb;
75(3):121-7.
PMID: 14978690
Peptide-pulsed dendritic cells can stimulate T cells showing specific cytotoxicity in chronic myelogenous leukemia. We tried to induce a specific cytotoxic T-cell response stimulated by RNA-pulsed dendritic cells in acute...
27.
Yoon J, Lee Y, Park C, Koe B, Kim I
Korean J Intern Med
. 2003 Jul;
18(2):122-4.
PMID: 12872452
Primary adrenal lymphoma is extremely rare. We describe a case of non-Hodgkin's lymphoma of diffuse large B-cell type with right adrenal involvement. The patient received chemotherapy and external irradiation and...
28.
Park W, Kim E, Kim B, Lee Y
Int J Oncol
. 2003 Jun;
23(1):197-204.
PMID: 12792794
Previously, we showed that monensin, Na+ ionophore, potently inhibited the growth of acute myelogenous leukemia and lymphoma cells. Here, we investigated the antiproliferative effect of monensin on human myeloma cell...
29.
Monensin-mediated growth inhibition of SNU-C1 colon cancer cells via cell cycle arrest and apoptosis
Park W, Kim E, Jung C, Kim B, Lee Y
Int J Oncol
. 2003 Jan;
22(2):377-82.
PMID: 12527937
Previously, we showed that monensin, Na+ ionophore, potently inhibited the growth of acute myelogenous leukemia and lymphoma cells. Here, we demonstrate that monensin inhibited the proliferation of solid tumor cells...
30.
Park W, Seol J, Kim E, Kang W, Im Y, Jung C, et al.
Br J Haematol
. 2002 Oct;
119(2):400-7.
PMID: 12406077
Monensin, a Na+ ionophore, regulates many cellular functions, including apoptosis. We investigated the in vitro antiproliferative effect of monensin on nine human lymphoma cell lines. Monensin significantly inhibited the proliferation...